18 May

Oncotarget: Towards Free Access to Information

Since its establishment in 2010, Oncotarget has grown in stature within scientific circles to become one of the leading scientific journals in the world. The medical journal published weekly under the sponsorship of Gordon Research Conference by Impact, primarily focuses on research-based and peer reviewed articles on cancer. However, over the years the journal has expanded the fields of its focus. Informed by the interconnectivity of cancer and other fields, the journal currently accepts articles on cellular and molecular biology among other fields. This ensures that the journal engages in a full frontal approach towards cancer: a scourge that has becoming a leading cause of deaths annually across the globe.

Oncotarget is committed towards ensuring that information on cancer and various related fields is available not only to the scientific community, but also to the general population. Towards this end, the journal operates an open source entity where all interested can submit and retrieved the peer-reviewed and researched articles online for free. Free generation and dispensation of information on cancer, other related conditions and other medical conditions, in general, is a major boost for the much-needed success towards finding a lasting and effective cure and therapies. Check the journal at SCImago Journal & Country Rank.

Quality Measures

Oncotarget has relatively positive ratings, which is reflective of the quality measures taken by the management of the journal. Before publication, all the articles undergo a rigorous peer review process carried out by multiple peers. These highly qualified professionals thoroughly vet the content of the articles before they are published for public consumption. In addition, the journal has highly qualified professionals sitting on its editorial board. The editorial board is composed of experienced scholars. Some of them including Mikhail Blagosklonny, its current editor-in-chief is a research scientist and professor with years of scholarly experience as an oncology specialist. Others are specialists in biology, cellular and molecular biology. This allows the journal to publish thoroughly vetted articles tackling different issues across various fields.

These quality measures have led to a Q1 ranking by Scopus/SJR. This is the highest ranking for journals by the entity. With over ten thousand citations for its articles, Oncotarget is one of the most popular journals globally when citation ratings are compared. Moreover, the journal has an impressive impact factor of 5.008 despite its relatively lifespan.

Know more: https://www.researchgate.net/journal/1949-2553_Oncotarget